The larger-than-life cut-outs and hoardings of political leaders are a sign of their penchant for profile-raising and personal aggrandisement ...

In this piece, we will look at the stocks Jim Cramer recently discussed. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer commented on President Trump’s latest set of tariffs.

Shares of Big Tech companies were sliding Monday morning, with Tesla Inc. tumbling the most in an exchange-traded fund focused on the so-called Magnificent Seven stocks, according to FactSet data ...

Actor Sivakarthikeyan has left for Sri Lanka for the next schedule of shooting of director Sudha Kongara's eagerly-awaited period action drama, 'Parasakthi'. Director Sudha Kongara had, last month ...

The S&P 500 bounced back on Tuesday after Wall Street finally got some good news out of Washington, D.C. The market benchmark was up 0.1% after falling to a level earlier in the day that would ...

More companies are signaling a weaker outlook for consumer spending. Downbeat forecasts are weighing on everything from airlines to retailer stocks this week. Consumer strength has been a key ...

Nvidia remains the company best positioned to benefit from increased AI infrastructure spending. Amazon has a history of spending big to win big, and it's spending big on AI. Alphabet has a strong ...

The Magnificent Seven stocks were getting hammered on Monday as part of a broader sell-off. All seven tech darlings were down, dragging the Nasdaq 100 index 4% lower. US stocks are fresh off their ...

U.S. stocks were lower, with the Nasdaq Composite falling around 650 points on Monday. Shares of Redfin Corporation RDFN rose sharply during Monday's session after Rocket Companies announced it ...

Mineralys Therapeutics enjoyed a big stock bump after its aldosterone synthase inhibitor chalked up wins in two types of hypertension. The therapy, called lorundrostat, hit the primary endpoint of ...